Clinical Trials in Ohio

Showing 6161-6180 of 15,929 trials

Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-002)

NCT02663622

This is a multicenter prospective phase IIa dose escalation and phase IIa expansion cohort clinical trial designed to evaluate the safety and tolerability of efprezimod alfa for acute GVHD prophylaxis.

Graft Versus Host DiseaseHematopoietic Stem Cell TransplantationLeukemia

Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)44 participantsStarted Sep 2016

Indianapolis, Indiana, United States • Ann Arbor, Michigan, United States • Detroit, Michigan, United States +1 more locations

No Longer Available81 miles

EPI-743 for Mitochondrial Respiratory Chain Diseases

NCT01370447

This study will evaluate the safety and efficacy of EPI-743 in participants with severe mitochondrial respiratory chain diseases who are considered to be within 90 days of end-of-life care.

Mitochondrial Diseases

PTC Therapeutics

Los Angeles, California, United States • Orange, California, United States • Palo Alto, California, United States +13 more locations

Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-002)

EPI-743 for Mitochondrial Respiratory Chain Diseases

Find Trials by Condition in Ohio

V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002)

A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS Trial

Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee

BIO 300 Non-Small Cell Lung Cancer Study

Incorporating Supersaturated Oxygen in Shock

A Study for Oral SY-2101 for Participants With Acute Promyelocytic Leukemia

A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis

Study to Evaluate the Effect of FX006 on Synovial Inflammation in Patients With OA of the Knee

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis

Study to Compare Exposure of TA Following Administration of Either FX006 or TAcs in Patients With Bilateral Knee OA

Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain

A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors

Growth and Tolerance of a Partially Hydrolyzed Infant Formula

A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic Keratosis

Clinical Study of the Solo+ Tympanostomy Tube Device

Study to Evaluate a Procedure for Intra-articular Injection of FX006 in Patients With Osteoarthritis of the Hip

Study on Efficacy and Safety of LNP023 in C3 Glomerulopathy Patients Transplanted and Not Transplanted